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ABSTRACT 
 To clarify to what extent topically administered drug molecules 
horizontally permeate into tissues surrounding the administration site, the 
intramuscular lateral concentration profile of acetaminophen was 
investigated in vivo using the microdialysis method in rats. When 
acetaminophen was intramuscularly administered for 6 hr in a pinpoint 
manner at a constant rate of 3 µg/min, it was clearly detected in the muscle 
surrounding the administration site, being 17.5 µg/ml when measured at a 2 
mm distance from the administration site. The concentration in the muscle 
was decreased as the distance increased, and those measured at 5 mm and 
40 mm were 0.35 µg/ml and 0.09 µg/ml, respectively. In addition, it was 
shown that the concentration in the muscle at 40 mm reflected the 
compound’s concentration in plasma, but not the compound’s horizontal 
permeation from the administration site. With these observations, the 
intramuscular distribution profile of acetaminophen was numerically 
characterized according to Fick’s law. As a result, it was revealed that 
horizontal permeation is the primary process accountable for the increased 
intramuscular concentration only in the area adjacent to the administration 
site, and the radius of the adjacent area was calculated to be 5.80 mm for 
acetaminophen. 
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1. Introduction 
 Intramuscular administration is one of the common ways to 
administer a therapeutic compound to patients parenterally. This is partly 
because a large enough amount of the compound to exert its therapeutic 
effects can be readily deposited in muscle with little pain and local irritation, 
as compared with other manners such as subcutaneous injection (Pratt, 
1990). In addition, as the pharmacological effects observed following 
intramuscular administration are usually exerted more slowly and last 
longer than those observed following intravenous administration, this 
administration manner is suitable when patients are unwilling to be 
frequently injected. It was indicated that the strength and duration of the 
pharmacological effects primarily depend on the rate and to what extent the 
administered compound enters the blood stream (Neubig, 1990), and various 
researchers have revealed that the entering process is dominated by several 
factors such as the compound’s molecular size (Nara et al., 1992a), 
interstitial diffusion coefficient (Nara et al., 1992b), and muscular blood flow 
rate (Rowland and Tozer, 1995). However, it has been poorly elucidated 
whether the administered compound remains in the administration site or if 
it horizontally permeates from the administration site to the surrounding 
tissues on entering the blood stream, though such information is 
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indispensable to optimize the design of intramuscularly-embedded 
drug-releasing devices to guarantee localized pharmacological effects and/or 
to minimize topical irritations (Maeda et al., 2003a,b).  
 One of the reasons for the lack of such information is due to 
difficulties in measuring the drug concentration in muscle in vivo. To date, 
several approaches have been proposed to overcome these difficulties, and 
among them, an approach using the microdialysis method seems to be the 
most suitable to evaluate the intramuscular drug concentration in vivo 
(Araki et al., 2002; Marchand et al., 2005). In this approach, a tiny probe 
equipped with a semi-permeable membrane is precisely embedded in muscle. 
When the lumen of the probe is filled with an isotonic solution, drug 
molecules, but not water, move through the semi-permeable membrane into 
the lumen according to the concentration gradient (Chaurasia, 1999). 
Therefore, the intramuscular drug concentration can be evaluated by 
collecting luminal specimens and determining their drug concentrations. 
 In this study, we clarified to what extend the intramuscularly 
administered compound permeates from the administration site into the 
surroundings in vivo with the microdialysis method in rats. For this purpose, 
we monitored the intramuscular drug concentration at various distances 
from the administration site. As a model compound, acetaminophen was 
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chosen because of its well-known characteristics and pharmacokinetics, and 
it was intramuscularly administered in a pinpoint manner at an 
administration site in the abdominal muscle. The intramuscular 
distribution profile of acetaminophen was then numerically analyzed and 
the extent of the compound’s horizontal permeation from the administration 
site into the surroundings was quantitated.  
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2. Materials and Methods 
2.1. Materials 
 Acetaminophen, or paracetamol (INN), was purchased from Tokyo 
Chemical Industry Co., Ltd. (Tokyo, Japan). Ringer’s solution was prepared 
according to the Japanese Pharmacopeia XIV using reagent grade chemicals 
obtained from local distributors. All other chemicals used in this study were 
of the finest grade available. 
 
2.2. Animals 
 Male Wistar rats (260–320 g) were purchased from Japan SLC Inc. 
(Hamamatsu, Japan). They were housed at 20–25°C and 40–50% humidity, 
and were allowed free access to a standard laboratory diet (MF, Oriental 
Yeast Co., Ltd., Tokyo, Japan) and water prior to the experiments. All 
animal experiments were performed in accordance with the guidelines for 
animal experimentation of Okayama University. 
 
2.3. Determination of the permeation coefficient of the microdialysis 
probe 
 Prior to each animal experiment, the permeation coefficient of the 
microdialysis probe was determined in vitro (Kurosaki, 1998). In brief, the 
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microdialysis probe assembly, which was equipped with a semi-permeable 
membrane (CMA/20, CMA Microdialysis AB, Solna, Sweden), was immersed 
in 2 µg/ml acetaminophen Ringer’s solution. The semi-permeable membrane 
used was 4 mm in length and 500 µm in diameter, and its permeation 
threshold was 20,000 daltons. The inlet and outlet of the probe assembly 
were connected to a syringe infusion pump (CMA/102, CMA Microdialysis 
AB, Solna, Sweden) and a fraction collector (CMA/142, CMA Microdialysis 
AB, Solna, Sweden), respectively. Then, the probe’s lumen began to be 
perfused with Ringer’s solution at a rate of 2 µl/min, and the perfusion 
effluent from the outlet was collected for 30 min. The collected effluent was 
used to determine the acetaminophen concentration, as described later. The 
permeation coefficient was calculated as the concentration ratio between the 
effluent and the original solution (2 g/ml).  
 
2.4. In vivo evaluation of the intramuscular acetaminophen 
concentration 
 After being anesthetized with ethyl carbamate (1 g/kg, i.p.), each rat 
was fixed on its back and the abdominal skin was gently removed to expose 
the muscle underneath. Then, three microdialysis probes were embedded in 
the abdominal muscle. The first probe was used to release the drug solution 
–9– 
in the muscle. For this purpose, we employed the retrodialysis method 
(Westerink and De Vries, 2001), by which it can be achieved to release the 
drug solution in a pinpoint manner and to keep the drug concentration 
constant at the administration site. The second and third probes were used 
to monitor the intramuscular drug concentration. To embed the first probe, 
the guide cannula with the microdialysis probe was placed at a distance of 
20 mm rightward from the midline, and it was inserted 2 mm deep into the 
abdominal muscle. Then, leaving its outer split tubing in the muscle, the 
needle of the guide cannula was replaced by the microdialysis probe. After 
that, by removing the split tubing, the microdialysis probe was firmly placed 
there. The inlet of the probe assembly was connected to the syringe infusion 
pump (CMA/102), and the outlet was connected to a drainage bottle. The 
location where the first probe was embedded is hereafter referred to as the 
administration site. Then, the second and third probes were embedded in 
the same manner as the first probe. The second one was embedded at 2, 5, 
10, or 15 mm leftward from the administration site. The third one was 
embedded at 40 mm leftward from the administration site, which was 20 
mm leftward from the midline. Each inlet of these two probes was connected 
to another infusion pump (CMA/102), and each of their outlets was 
connected to the fraction collector (CMA/142).  
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 Following a 30-min equilibration period, the probes simultaneously 
began to be perfused at a rate of 2 µl/min. The first probe was perfused with 
10 mg/ml acetaminophen Ringer’s solution, and the second and third probes 
were perfused with unmodified Ringer’s solution. The collection of the 
effluents from the second and third probe outlets also began. The effluent 
was collected every 30 min until 2 hr, and every 60 min until 6 hr. 
Acetaminophen in the collected effluents was determined by means of HPLC 
as described later, and the intramuscular concentration was then calculated 
taking account of the probe’s permeation coefficient that was evaluated prior 
to the experiment. In addition, a 200-µl blood sample was drawn from the 
jugular vein at 30, 60, 90, 120, 240, and 360 min during the experimental 
period. Blood samples were centrifuged, and plasma was collected. The 
acetaminophen concentration in the plasma specimens was also determined 
as described later. During the experiment period, the rat was maintained to 
be anesthetized, and it was kept warm with heating apparatuses.  
 
2.5. Determination of the plasma protein binding ratio of acetaminophen 
 With freshly prepared rat plasma specimens, acetaminophen plasma 
solution was prepared at a final concentration of 1, 2, and 5 µg/ml, 400-µl of 
which was applied to the MPS® micropartition ultrafiltration device 
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(Millipore, Billerica, MA, USA). The unbound fraction of acetaminophen was 
separated by centrifugation (1,500×g, 10 min) at room temperature 
(Nakayama et al., 1997). The acetaminophen concentration was determined 
as described later.  
 
2.6. Analytical procedure 
 To evaluate the relationship between the intramuscular and plasma 
concentration of acetaminophen, an interpolation of the observed plasma 
concentration data was carried out using the following equation: 
  )1()( tkess eCptCp ⋅−⋅−⋅=      (1) 
where Cp(t) is the plasma concentration of acetaminophen at time t. The 
elimination rate constant and the plasma acetaminophen concentration at a 
steady-state are designated as ke and Cpss, respectively. These two 
parameters were determined with non-linear least square calculation based 
on the observed concentration data (Yamaoka et al., 1981). 
The intramuscular distribution profile of acetaminophen was 
characterized in a model-dependent manner with the following equations: 
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where C is the intramuscular concentration of acetaminophen at time t and 
at distance x from the administration site. D is the apparent diffusion 
coefficient of acetaminophen in muscle, and K is the rate constant at which 
the concentration C changes according to the concentration gradient 
between muscle and plasma. The plasma concentration of acetaminophen 
and its plasma unbound fraction are denoted as Cp(t) and fu, respectively. 
The parameters D and K were estimated based on the observed 
intramuscular concentration profiles with non-linear least square 
calculation utilizing the fast inverse Laplace transform algorithm (Yano et 
al., 1989). 
 
2.7. Assay method 
 The acetaminophen concentration was determined by means of 
HPLC equipped with an octadodecyl silica column (4 µm, 4.6 × 150 mm, 
Synergi Fusion-RP, Phenomenex, Torrance, CA, USA). The collected 
effluents and the unbound fraction of the acetaminophen were directly 
applied to HPLC. The plasma specimen was deproteinized before 
application, in which it was mixed with three volumes of methanol followed 
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by vigorous agitation and centrifugation, and 20-µl of each sample was 
applied to HPLC. As a mobile phase, 20% methanol–80% phosphate buffer 
(pH 3.5) was used. The flow rate was set at 1.0 ml/min. Acetaminophen was 
spectrometrically determined at a wave length of 245 nm.  
 
2.8. Statistics 
 Data are shown as the mean ± S.E.M. for 3–5 experiments. Multiple 
comparisons against a single control were performed by Dunn’s 
nonparametric test, and p<0.05 was considered to indicate significance. 
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3. Results and Discussion 
3.1. Evaluation of intramuscular concentration-time and concentration- 
distance profiles of acetaminophen in vivo  
 The permeation coefficient of the microdialysis probe that was 
determined prior to each experiment was 38.9 ± 3.0% on the average. When 
the acetaminophen concentration was examined in the muscle surrounding 
the administration site, it was clearly detected at a 2, 5, 10, 15, and 40 mm 
distance from the administration site (Fig. 1A). At a 2 mm distance, the 
concentration in the muscle was increased to 17.52 ± 0.95 µg/ml for 75 min, 
and then it became nearly constant at that value (Fig. 1A). The 
concentration value at 5 mm varied in a similar manner to that at 2 mm, 
being increased to a constant level of 0.35 ± 0.01 µg/ml for 105 min. On the 
other hand, the concentration values at 10, 15, and 40 mm varied in an 
indistinguishable manner from each other, and they reached a constant 
level of 0.090–0.098 µg/ml around 150 min (Fig. 1A). This finding indicated 
that acetaminophen gradually permeates into the surroundings after 
administration, and thereby the acetaminophen concentration in the muscle 
is increased, as observed. However, the impact of permeation on the 
acetaminophen concentration in the muscle tended to become unnoticeable 
as the measurement distance was increased. This tendency was clearly 
–15– 
shown when the concentration-distance profile was examined at the end of 
the experimental period (Fig. 1B). That is, although the concentration 
rapidly decreased when the distance was increased from 2 to 5 mm, it was 
not further decreased when the distance was increased from 10 to 15 or 40 
mm. The permeation seemed to influence the acetaminophen concentration 
in the muscle only in the area adjacent to the administration site.  
 
3.2. Evaluation of the relationship between the intramuscular and 
plasma acetaminophen concentrations 
 Since compounds which are introduced into the blood stream 
distribute to whole tissues including muscle, as reported (Araki, 2002), we 
monitored the change in the unbound concentration of acetaminophen in 
plasma to examine its relationship to the concentration in muscle. The 
plasma protein binding ratio of acetaminophen was determined to be 33.7 ± 
2.3%. During the experiment, the unbound concentration of acetaminophen 
in plasma was gradually increased (Fig. 2). When the concentration profile 
in plasma was compared with that in muscle measured at 40 mm, these two 
profiles were shown to be proportionally related to each other, and the 
proportional ratio became nearly constant at 0.268 ± 0.001 as the time 
elapsed (Fig. 2). This finding suggested that the concentration in the muscle 
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becomes to mainly reflect the concentration in plasma as the distance from 
the administration site is increased. 
 
3.3. Numerical analysis of intramuscular distribution of acetaminophen 
 To determine to what extent acetaminophen horizontally permeates 
into the surroundings from the administration site, the concentration 
profiles in muscle were numerically analyzed, taking account of the 
influence of the plasma concentration. The observed concentration profiles 
were well explained with the diffusion equation based on Fick’s law (Fig. 1A), 
and the diffusion coefficient D and the rate constant K were calculated to be 
0.0382 ± 0.0013 mm2/min and 0.0737 ± 0.0030 min-1, respectively. It was 
reported that the diffusion coefficient of glucose, which has a similar 
molecular weight to acetaminophen (180.16 vs. 151.17, respectively), is 
0.0546 mm2/min (Pratt, 1990). This value is comparable to that of 
acetaminophen calculated in this study, suggesting that the intramuscular 
distribution of therapeutic compounds can be adequately evaluated in vivo 
with our microdialysis approach. However, further investigations may be 
necessary to precisely determine the diffusion parameters for the 
intramuscularly administered compounds, taking into account of a variation 
of the muscle blood flow rate and/or influences of the concentration of the 
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applied compound.  
 Then, the concentration-distance profile of acetaminophen in muscle 
was calculated with the determined values of D and K (Fig. 3A). It was 
indicated that the concentration in muscle was rapidly decreased to 0.36 
µg/ml at 5 mm, being 0.12% of the initial value at the administration site 
(Fig. 3A). To evaluate the extent of horizontal permeation, we defined the 
adjacent area as that where horizontal permeation from the administration 
site influences the concentration in the muscle more dominantly than a 
change in the plasma concentration. Based on this definition, we calculated 
the distance from the administration site at which the concentration in the 
muscle was 2 times higher than the background concentration level 
calculated from the plasma concentration (0.091 µg/ml). The distance, 
namely the radius of the adjacent area, was determined to be 5.80 mm in 
the case of acetaminophen (Fig. 3A).  
 Since the concentration-distance profile varies depending on the 
apparent diffusion coefficient D and the rate constant K, the change in the 
radius of the adjacent area was examined with these two parameters being 
altered. It was indicated that the radius is increased as the parameter D is 
increased and/or the parameter K is decreased (Fig. 3B). Therefore, when 
compounds are aimed to be effectively dispersed in the muscle surrounding 
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the administration site, a small compound is more advantageous than a 
large one from the viewpoint of an increase of the parameter D. It is also 
preferable to prevent the compound from entering the blood stream because 
of a decrease of the parameter K. On the other hand, lowering the 
temperature around the administration site may be preferable to confine the 
compound within the administration site because the parameter D is 
decreased, and thus the compound’s horizontal permeation is suppressed. 
These findings provide useful information to increase the efficiency of 
therapeutic compounds. An increased efficiency of an anti-inflammatory 
compound which is topically applied to treat muscle pains may be achieved 
by cooling the application site to confine the compound there, for example. 
In addition, our approach to evaluate the intramuscular distribution of 
compounds can be utilized in a process to optimize the design of 
intramuscularly-embedded drug-releasing devices to minimize their adverse 
side-effects, in which topical irritations are likely to be reduced by 
suppressing the compound’s horizontal permeation into the muscle 
surrounding the embedment site. 
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4. Conclusions 
 It was demonstrated that acetaminophen horizontally permeated 
into the muscle surrounding the administration site following its 
intramuscular administration. In the area adjacent to the administration 
site, the acetaminophen concentration in the muscle was increased due to 
horizontal permeation, but it was rapidly decreased as the distance from the 
administration site was increased. Numerical analysis indicated that the 
radius of the adjacent area was 5.80 mm for acetaminophen, and the 
simulation showed that the radius is increased as the compound’s diffusion 
coefficient is increased and/or the rate constant of the compound entering 
the blood stream is decreased.  
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Legends for Figures 
Fig. 1. Intramuscular concentration–time (panel A) and concentration– 
distance (panel B) profiles of acetaminophen in rats. Panel A: The 
intramuscular concentration of acetaminophen measured at a 2, 5, 
10, 15, and 40 mm distance from the application site are indicated 
with open circles, open diamonds, open triangles, open squares, 
and closed circles, respectively. Dotted lines are the best fit lines 
obtained from numerical analysis of the acetaminophen 
distribution (see text). Panel B: The intramuscular concentration 
values measured at the end of the experiment were compared. 
Data are shown as the means ± S.E.M. of 3–5 experiments. 
*p<0.05; significantly different from the value at 40 mm. 
 
Fig. 2. Relationship between the plasma and intramuscular concentration 
profiles of acetaminophen. The plasma unbound concentration 
profile of acetaminophen is shown with closed triangles, and the 
intramuscular concentration profile measured at 40 mm is shown 
with closed circles. The concentration ratio is indicated with the 
symbol ‘×’, which was calculated by dividing the intramuscular 
concentration by the corresponding value in the unbound plasma 
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concentration profile that was obtained by interpolation. The 
dotted line is the best fit line calculated to interpolate the plasma 
concentration profile. Data are shown as the means ± S.E.M. of 4 
experiments. Some error bars are covered over by symbols. 
 
Fig. 3. Numerical characterization of the intramuscular concentration 
profile of acetaminophen. Panel A: The intramuscular distribution 
of acetaminophen at the end of the experimental period was 
simulated up to 8 mm from the administration site. The 
administration site is indicated with the symbol ‘•’. Outline A, B, 
and C designate the distances at which the acetaminophen 
concentration is 10, 5, and 2 times higher than the background 
level (0.091 µg/ml), respectively. The radii of A, B, and C are 4.21, 
4.80, and 5.80 mm, respectively. A part of the profile has been 
removed for explanation. Panel B: The change in the radius of the 
outline C is shown. The radius was referred to as the radius of the 
adjacent area (see text). The calculation was performed with the 
parameters D and K being changed 0.4—2.4 fold over their 
original values (0.0382 mm2/min for D, and 0.0737 min-1 for K). 
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